Biosimilars have garnered significant press over the past few years, with a primary focus on savings for employers. This savings is significant, as increased use of biosimilars will allow for a more competitive drug marketplace. Reduced barriers to biosimilar adoption could generate savings of...
National Alliance 2022 Employer Strategies in Biosimilars FINAL 02-25-2022.pdf
National Alliance of Healthcare Purchaser Coalitions1015 18th Street, NW, Suite 705Washington, DC 20036(202) 775-9300 (phone)(202) 775-1569 (fax)
National Alliance WebsiteJoinWhat We DoContact UsTerms and Conditions